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Abstract 
Background 
The metabolic syndrome is progressively more common worldwide. It is linked with the rise in obesity and 
lifestyle risk behaviors. It is also controversial; its value in predicting cardiovascular disease and diabetes risk 
and in guiding therapy has been challenged. 
Objective 
This article objective is to provide guidance on the diagnosis of the metabolic syndrome and the values for its 
prevention and management in perspective of primary care, taking into consideration etiological factors and the 
difficulty of managing its constituent risk factors. 
Discussion 
Diagnosis of metabolic syndrome is useful in focusing attention on central adiposity and insulin resistance as 
risk factors both for the syndrome, cardiovascular and diabetes morbidity and mortality. Its assessment requires 
measurement of waist circumference, a simple but not often performed procedure in general practice in Albania.  
Conclusion 
The most essential components for the prevention and management of the metabolic syndrome are measures to 
change diet and physical activity in order to accomplish and continue weight loss. 
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Introduction 
The metabolic syndrome is increasingly widespread, national wide and in the world as well. Recent studies, 
found that each year 3.2 million people around the world die from complications associated with diabetes.
1, 2, 3, 4
 
Type 2 diabetes, which accounts for 80-90 % of all diabetes, has become one of the major causes of premature 
illness and death, mainly through the increased risk of cardio vascular diseases - CVD which is responsible for 
up to 80 %of these deaths.
4
 In most people with glucose intolerance or type 2 diabetes, there is a multiple set of 
risk factors that commonly appear together, forming what is now known as Metabolic Syndrome. 
The cardiovascular complications of diabetes, which is also a foremost cause of blindness, amputation 
and kidney failure, relation for to a great extent of social and economic burden of the disease. The forecast that 
diabetes incidence will double by 2025 indicates a corresponding rise in cardiovascular associated illness and 
death, with an inevitable and deep impact on global healthcare systems in general. 
 
Discussion 
Metabolic syndrome is a growing epidemic throughout the world. Approximately 1 adult in every 4 or 5, 
depending on the country, has metabolic syndrome.
1, 2,
 
3, 4
 The incidence increases with age; it has been 
estimated that in people over 50 years of age, metabolic syndrome affects more than 40% of the population in 
the United States of America and nearly 30% in Europe.
3, 4
 The worldwide prevalence of obesity has doubled in 
the last two decades. The prevalence of obesity and metabolic syndrome varies between different countries and 
ethnic groups.
3, 4, 5 
Metabolic syndrome it is not only an epidemiological clustering of risk factors, but also has a common 
underlying patho-physiological cause: insulin resistance associated with central adiposity. These are in turn 
related to underlying genetic and early life influences and a range of lifestyle risk factors, including sleep 
deprivation and physical inactivity. 
Until recently, there has been a multiplicity of definitions. This has been resolved in 2009 by the 
publication of a joint statement and a single definition agreed to by a number of relevant national and 
international bodies. According to the new International Diabetes Federation (IDF) and American Heart 
Association (AHA) definition in 2009, any three (or more) of the following factors constitutes a diagnosis of 
metabolic syndrome: 
Increased waist circumference: ethnicity specific - eg, Caucasian men ≥94 cm and women ≥80 cm; 
South Asian men ≥90 cm and women ≥80 cm. 
If body mass index is over 30 kg/m
2
, central obesity can be assumed and waist circumference does not 
need to be measured. 
Raised triglycerides: 
>150 mg/dL (1·7 mmol/L) 
Or specific treatment for this lipid abnormality 
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Reduced HDL-cholesterol: 
<40 mg/dL (1·03 mmol/L) in men 
<50 mg/dL (1·29 mmol/L) in women 
Or specific treatment for this lipid abnormality 
Raised blood pressure: 
Systolic ≥130 mm Hg 
Diastolic ≥85 mm Hg 
Or treatment of previously diagnosed hypertension 
Raised fasting plasma glucose: 
Fasting plasma glucose ≥100 mg/dL (5·6 mmol/L) 
Most people with type 2 diabetes will have metabolic syndrome based on these criteria 
In Albania, unfortunately we medical professionals face medical cultural challenge in patient clinical assessment 
approach. In primary care settings waist circumference is not evaluated, not because of lack of means rather than 
not appreciating the significance. Another difficulty is the laboratory service access in primary health care 
system that is not available and therefore making the road of diagnosis long enough to discencourage the 
population to profit from medical system stated by law.   
 
Conclusion 
A professional approach to metabolic syndrome requires addressing several risk factors together. The most 
essential components for the prevention and management of the metabolic syndrome are measures to change diet 
and physical activity in order to accomplish and continue weight loss. 
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